Archive for the ‘research’ Category

Case Series Shows Wide Range of Babesia Symptoms & Presentations

https://danielcameronmd.com/case-series-shows-wide-range-babesia-symptoms-presentations/

CASE SERIES SHOWS WIDE RANGE OF BABESIA SYMPTOMS AND PRESENTATIONS

babesia-symptoms

Babesia can be a serious tick-borne illness in some patients. A case series published in the Nurse Practitioner Journal demonstrates the difficulty in diagnosing the disease, as it can cause a wide range of clinical presentations. The authors focus on five cases which occurred in southeastern New Jersey, an area endemic for Babesia. All of the patients were hospitalized.

This case series describes a broad range of Babesia symptoms in elderly patients, making the diagnosis particularly challenging.

Case 1: A 78-year-old white female was admitted with fever, chills, lethargy, fatigue, and marked changes in sensorium. “She had a maximum temperature of 100.6° F (38.1° C); sepsis was considered for this patient,” writes Paparone, a Nurse Practitioner (NP) from the Atlantic County Health Department in Northfield, New Jersey. A tick-borne illness was considered, in part due to multiple tick bites, abnormal liver function tests, anemia, and thrombocythemia. “Peripheral smear was positive for Babesia, and she had a Babesiaimmunoglobulin M (IgM) of 1:160 and Anaplasma (previously referred to as Ehrlichia) IgM of 1:320.” [1]

The woman’s mentation and lethargy dramatically improved when treated with a combination of doxycycline, atovaquone and zithromax.

Case 2: A 90-year-old white female was admitted for rectal bleeding with a hemoglobin of 7.6 g/dL and low platelet count of 103 × 109/L. The bleeding resolved with an octreotide infusion. The woman also had fever spikes to 100° F and a positive smear for Babesia. Her illness resolved with azithromycin and atovaquone.

Case 3: A 57-year-old white male was admitted with fever, malaise, and chills. His temperature had risen to 101° F during his 5-day hospital stay. Anaplasmosis was suspected due to his elevated liver enzymes, leukopenia, and thrombocytopenia. Intravenous doxycycline, oral clindamycin and quinine were prescribed. But he tested positive for Babesia. His hospital course was complicated by acute hearing deterioration. Quinine was stopped and his treatment was changed to oral azithromycin and oral atovaquone.

Case 4: An 81-year-old white male was admitted with increasing lethargy, weakness, chills, and blurred vision. Babesia was diagnosed on peripheral smear. Anaplasmosis was suspected based on anemia and thrombocytopenia.

Subsequently, serologic studies demonstrated an Anaplasmosis IgG of 1:256, Babesia IgM and IgG of 1:320. He was discharged after a 10-day combination of azithromycin and doxycycline. There was no evidence Babesia was treated during the hospitalization.

“At discharge on day 10, [he] was switched to clindamycin orally three times a day and quinine orally three times a day because of intolerance to azithromycin, and he completed a 14-day course of therapy,” writes Paparone.

Case 5: An 85-year-old white male was admitted with intermittent recurring fevers and chills. “He had a history of hairy cell leukemia, splenectomy, atrioventricular block (pacemaker), gouty arthritis, prostatic hypertrophy, and polymyalgia rheumatica,” writes Paparone. Babesia was diagnosed with 10.4% of his red blood cells infected. He was prescribed oral azithromycin and atovaquone. Doxycycline was added due to the possibility of a concurrent tick-borne infection.

He was discharged on day 8 only to be readmitted with an inability to ambulate and generalized weakness. His peripheral smear was positive for Babesia. “Due to the persistence of parasitemia despite adequate therapy, he was changed to clindamycin,” according to Paparone. His treatment was changed back to azithromycin and atovaquone due to gastric distress and a generalized erythematous coalescing rash. A peripheral smear for Babesia was negative at 5.5 weeks.

Each of the five cases presented differently: 

  1. Fever, chills, lethargy, fatigue, and marked changes in sensorium
  2. GI bleed
  3. Fever, malaise, and chills
  4. Increasing lethargy, weakness, chills, and blurred vision
  5. Intermittent recurring fevers and chills

Co-infections 

Three of the five cases with babesia symptoms were treated for co-infections without confirmatory serologic tests. Two of three cases were treated for Anaplasmosis without serologic confirmation.

Treatment tolerance

Zithromax and atovaquone were well tolerated in a population of patients with babesia symptoms that included 4 elderly patients ranging from 78 to 90 years old. Quinine was stopped due to hearing loss in one subject. Clindamycin and quinine were stopped in a second subject due to gastric distress and a generalized erythematous coalescing rash.

There was no evidence any of the 5 subjects babesia symptoms required blood transfusions despite their anemia and thrombocytopenia. This suggests that prompt recognition of Babesia in the hospital setting might avoid the transfusions described in the literature.

Babesia was successfully treated even in their immunocompromised patient, who was treated with exchange transfusion due to persistent parasitemia. “Red blood cell exchange transfusions are recommended for cases of severe babesiosis in patients with parasitemia of 10% or greater, severe anemia (hemoglobin less than 10 g/dL), or pulmonary, kidney or liver impairment,” writes Paparone. “Exchange transfusions are used to rapidly decrease parasitemia, correct anemia, and help remove toxic byproducts produced by the infection.”

Authors’ recommendations  

“This case series illustrates the need for the NP to appreciate the variable clinical presentations of babesiosis to facilitate prompt diagnosis, provide proper therapeutic management, and avoid the poor outcomes associated with this disease.” [1]

• It is important for the NP to understand that infected patients may not recall a tick bite and that clinical presentations may not only be variable but also nonspecific, ranging from subclinical to severe.

• The possibility of co-infection with other tick-borne illnesses (Lyme disease and anaplasmosis) must be considered.

• Furthermore, the NP needs to assume an active role in patient education to affect babesiosis awareness and prevention.

References:
  1. Paparone, P. and P.W. Paparone, Variable clinical presentations of babesiosis: A case series. Nurse Pract, 2017. 42(11): p. 1-7.

_________________________

For more:

Dermatological & Genital Manifestations of Lyme Disease Including Morgellons Disease

https://www.dovepress.com/dermatological-and-genital-manifestations-of-lyme-disease-including-mo-peer-reviewed-fulltext-article-CCID

Dermatological and Genital Manifestations of Lyme Disease Including Morgellons Disease

Authors Middelveen MJ, Haggblad JS, Lewis J, Robichaud GA, Martinez RM, Shah JS, Du Cruz I, Fesler MC, Stricker RB

Received 5 January 2021

Accepted for publication 9 April 2021

Published 6 May 2021 Volume 2021:14 Pages 425—436

DOI https://doi.org/10.2147/CCID.S299526

Article has an altmetric score of 23

Download Article [PDF] 

Abstract: Although the erythema migrans (EM) skin rash is traditionally considered a hallmark of Lyme disease, other dermatological manifestations of the tickborne disease are less well known. We describe a 49-year-old woman with erosive genital ulcerations, secondary EM rashes and jagged skin lesions associated with Lyme disease. The skin rashes exhibited fibers characteristic of Morgellons disease. Molecular testing confirmed the presence of Borrelia DNA in both vaginal culture and serum specimens. In further studies on a secondary EM lesion containing filaments, Gömöri trichrome staining revealed the presence of collagen in the filaments, while Dieterle and anti-Borrelia immunostaining revealed intracellular and extracellular Borrelia organisms. Intracellular staining for Borrelia was also observed in lymphocytic infiltrates. Lyme disease may present with a variety of genital lesions and dermatological manifestations including Morgellons disease. Careful evaluation is required to determine the presence of Borreliaorganisms associated with these dermopathies.

____________________

**Comment**

Morgellons patients in many ways suffer worse than Lyme patients.  Most doctors still believe Morgellons is a figment of the imagination, while Lyme is getting some air-time and recognition – which unfortunately, doesn’t mean things are changing for the better.

This new case study is reminiscent of previous work done by some of the same study researchers:

  • https://madisonarealymesupportgroup.com/2019/05/20/vaginal-lesion-associated-with-lyme/  This 57-year-old woman previously diagnosed with Lyme disease had a painful erosive genital lesion. At the time of the outbreak, she was being treated with oral antibiotics, and she tested serologically positive for B burgdorferi and serologically negative for syphilis. Dieterle-stained biopsy sections revealed visible spirochetes throughout the stratum spinosum and stratum basale, and anti-B burgdorferi immunostaining was positive. Motile spirochetes were observed by darkfield microscopy and cultured in Barbour-Stoner-Kelly-complete medium inoculated with skin scrapings from the lesion. Cultured spirochetes were identified genetically as B burgdorferi sensu stricto by polymerase chain reaction, while polymerase chain reaction amplification of treponemal gene targets was negative. The condition resolved after treatment with additional systemic antibiotic therapy and topical antibiotics. 
  • https://f1000research.com/articles/3-309/v3  Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions.  This study has gone through 3 versions dating from December, 2014-April 2015.  Only 2 of 4 reviewers approved it.  Results:  Control subjects who were asymptomatic and seronegative for Bb had no detectable spirochetes in genital secretions by PCR analysis. In contrast, spirochetes were observed in cultures of genital secretions from 11 of 13 subjects diagnosed with Lyme disease, and motile spirochetes were detected in genital culture concentrates from 12 of 13 Lyme disease patients using light and darkfield microscopy. Morphological features of spirochetes were confirmed by Dieterle silver staining and immunohistochemical staining of culture concentrates. Molecular hybridization and PCR testing confirmed that the spirochetes isolated from semen and vaginal secretions were strains of Borrelia, and all cultures were negative for treponemal spirochetes. PCR sequencing of cultured spirochetes from three couples having unprotected sex indicated that two couples had identical strains of Bb sensu stricto in their semen and vaginal secretions, while the third couple had identical strains of B. hermsii detected in their genital secretions.  Conclusions: The culture of viable Borrelia spirochetes in genital secretions suggests that Lyme disease could be transmitted by intimate contact from person to person. Further studies are needed to evaluate this hypothesis.  
  • Lida Mattman has isolated Bb from many sources, including semen, urine, blood, plasma, and CSF:  https://madisonarealymesupportgroup.com/2019/04/02/transmission-of-lyme-disease-lida-mattman-phd/
  • Lyme advocate Carl Tuttle points out that 45 lab acquired infections with Borrelia burgdorferi are on record, all of which were NOT vector-borne (didn’t come from a tick bite). How did these workers get infected?   https://madisonarealymesupportgroup.com/2019/04/14/lab-acquired-infections-lyme/

More on Morgellons:

Chronic Bartonella Infections in Animals and Humans: Crypto-Infections Conference

Chronic Bartonella Infections in Animals and Humans

2nd European Crypto-Infections Conference

Catherine McAuley Center, Dublin, Ireland

September 26-27, 2020

Presentation by Bruno B. Chomel, Distinguished Professor of Zoonoses

Department of Population Health and Reproduction,

School of Veterinary Medicine,

University of California, Davis, CA, USA

Bartonella-endocarditis-Dublin-2020-Bruno-Chomel(3)  Slides Here

___________________

For more:

Kidney Failure & Disseminated Rashes Associated With Lyme Disease

https://danielcameronmd.com/kidney-failure-associated-with-lyme-disease/  Podcast Here

KIDNEY FAILURE AND DISSEMINATED RASHES ASSOCIATED WITH LYME DISEASE

kidney-failure-lyme-disease

Hello, and welcome to another Inside Lyme Podcast. I am your host Dr. Daniel Cameron. In this episode, I will be discussing the case of a 66-year-old woman who ignored a Bull’s eye rash, indicative of Lyme disease, and later developed acute renal failure, also referred to as kidney failure.

Mishra and colleagues described this case, entitled “Disseminated Erythema Migrans,” in the American Journal of Medicine. [1]

CASE REPORT: Kidney failure, disseminated rashes associated with Lyme disease

Over a two-week period, a 66-year-old woman with a history of obesity, hypertension, and hyperlipidemia, developed fever and malaise.

One month earlier, she reportedly had a tick bite on her right groin. “A few days later she noticed a bull’s eye lesion over the same area which she ignored,” the authors explain.

READ MORE: Doctors recognize Lyme disease in a patient with kidney disease

I can’t tell you how many patients I have had in my practice who ignore the importance of a tick bite or a rash.

The woman developed clear findings of disseminated Lyme disease. She had “high grade, intermittent fever, malaise, and fatigability,” along with “multiple, painless, red color skin lesions involving her arms, legs and lower back,” the authors write.

Early disseminated Lyme disease typically occurs shortly after a tick bite when the infection has spread throughout the body.  

The patient was hospitalized and found to have unexplained acute renal failure (or kidney failure) with a creatinine of 4.49 mg/dl.  Normal levels are closer to 1. (Dialysis is typically necessary if the creatinine were to stay over 5.)

The woman’s IgM Western blot test was positive which is expected in early Lyme disease.

She was treated clinically with IV ceftriaxone and oral doxycycline. “Her renal functions improved following hydration, antibiotics, and discontinuation of her losartan and non-steroidal anti-inflammatory drugs,” the authors explain.

The following questions are addressed in this podcast episode:

  1. What is the importance of the rash in this case?
  2. When does an EM rash typically appear?
  3. A rash will fade after a few days? Does this mean that Lyme disease is no longer a concern?
  4. This patient had multiple disseminated rashes. How common is this and what does it indicate?
  5. Does a rash always appear at the site of the tick bite?
  6. What is the risk of Lyme disease from a tick?
  7. What is the risk of Lyme disease once a rash is identified?
  8. How often are there treatment delays, even when a rash is present?
  9. What types of treatment delays have you seen?
  10. What are the consequences of delayed treatment?
  11. Have you seen kidney failure associated with Lyme disease?
  12. Could this patient’s hospitalization and kidney failure have been prevented?
  13. Have you seen kidney failure in dogs associated with Lyme disease?
  14. Do you feel treatment was appropriate in this case?
  15. What can we learn from this case?
    Thanks for listening to another Inside Lyme Podcast. You can read more about these cases in my show notes and on my website @DanielCameronMD.com. As always, it is your likes, comments, reviews, and shares that help spread the word about Lyme disease. Until next time on Inside Lyme.

Please remember that the advice given is general and not intended as specific advice as to any particular patient. If you require specific advice, then please seek that advice from an experienced professional.

Inside Lyme Podcast Series

This Inside Lyme case series will be discussed on my Facebook and made available on podcast and YouTube.  As always, it is your likes, comments, and shares that help spread the word about this series and our work. If you can, please leave a review on iTunes or wherever else you get your podcasts.

Can Lyme Disease Stay With You Forever?

https://danielcameronmd.com/does-lyme-disease-stay-with-you-forever/

CAN LYME DISEASE STAY WITH YOU FOREVER? ASK THE LYME DOC.

does-lyme-disease-stay-with-you-forever

All too often, physicians assume that Lyme disease is easy to diagnose and treat. But for those clinicians treating tick-borne illnesses on a regular basis, Lyme disease is clearly a complex illness that is frequently misdiagnosed and challenging to treat with some patients experiencing chronic, long-lasting symptoms. Doctors treating Lyme disease are often asked by patients: Does Lyme disease stay with you forever or can it be cured?

Can Lyme disease stay with you forever? Although many patients will improve with appropriate treatment, others will experience ongoing Lyme disease symptoms that may stay with them forever. A growing number of case studies continue to document patients with chronic illnesses associated with Lyme disease.

Following are several examples:

Chronic neurologic Lyme disease

In the New England Journal of Medicine, Logigian and colleagues described patients with chronic neurologic Lyme disease who had been ill for years. [1] Their symptoms included fatigue, poor sleep, cognitive impairment, irritability, headaches, lightheadedness, and joint pain. Some of the patients improved with antibiotic treatment but symptoms eventually reoccurred. Others failed treatment. The authors expressed concern that treatment may not have eradicated the infection.

Neuropsychiatric Lyme disease

Fallon and colleagues described patients with Lyme disease, who were initially presumed to have a psychiatric illness. [2] The patients had been diagnosed with “paranoia, dementia, schizophrenia, bipolar disorder, panic attacks, major depression, anorexia nervosa, and obsessive-compulsive disorder.”

Lyme encephalopathy

In another study, Fallon et al. described individuals with Lyme disease who had been ill an average of 9 years. These patients had failed on average of two previous treatments, with many of them failing retreatment.

Post-Treatment Lyme Disease Syndrome*

Rebman and colleagues found that despite antibiotic treatment, patients with Post-Treatment Lyme Disease Syndrome (PTLDS) remained ill with pain, fatigue, impaired cognitive function, and poor functioning. [3]

Central Sensitization Syndrome and Pain

Researchers have described central sensitization syndrome in patients with Post-Treatment Lyme Disease Syndrome. “The primary symptoms of central sensitization include pain, fatigue, and sensory hyperarousal.” [4] Meanwhile, Hanna et al. discussed the case of a woman with PTLDS who experienced chronic, severe pain. [5]

Postural Orthostatic Tachycardia Syndrome (POTS)

Kanjwal and colleagues described 5 Lyme disease patients who developed a type of autonomic dysfunction called Postural Orthostatic Tachycardia Syndrome (POTS). “These patients developed symptoms of fatigue, cognitive dysfunction, orthostatic palpitations and either near syncope or frank syncope.” [6]

Furthermore, they added, “The debilitating nature of these symptoms had resulted in loss of the employment or inability to attend school. Three patients were also suffering from migraine, two from anxiety and depression and one from hypertension.”

Pediatric Acute-onset Neuropsychiatric Syndrome

In some individuals, Lyme disease has been associated with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), which is characterized by the onset of several neurologic and/or psychiatric symptoms. Swedo and colleagues have suggested further studies to determine whether Lyme disease could lead to PANS. [7]

Death

In the CDC’s Morbidity and Mortality Weekly Report, clinicians described 5 deaths due to Lyme carditis, [8] while Yoon and colleagues described a 17-year-old man who died of Lyme carditis [9] and another study reported a female patient who died from the tick-borne illness Babesia. [10]

Editor’s note: Can Lyme disease stay with you forever? It certainly seems so.  I am not in favor of the term Post-Treatment Lyme Disease Syndrome until there is a reliable test to demonstrate the absence of a persistent infection.

References:
  1. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323(21):1438-1444.
  2. Fallon BA, Nields JA. Lyme disease: a neuropsychiatric illness. Am J Psychiatry. 1994;151(11):1571-1583.
  3. Rebman AW, Bechtold KT, Yang T, et al. The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome. Front Med (Lausanne). 2017;4:224.
  4. Batheja S, Nields JA, Landa A, Fallon BA. Post-treatment lyme syndrome and central sensitization. J Neuropsychiatry Clin Neurosci. 2013;25(3):176-186.
  5. Hanna AF, Abraham B, Hanna A, Smith AJ. Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome. Int Med Case Rep J. 2017;10:305-308.
  6. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Postural orthostatic tachycardia syndrome following Lyme disease. Cardiol J. 2011;18(1):63-66.
  7. Swedo SE, Leckman JF, Rose NR. From Research Subgroup to Clinical Syndrome: Modifying the PANDAS Criteria to Describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Pediatrics & Therapeutics.1-8.
  8. Muehlenbachs A, Bollweg BC, Schulz TJ, et al. Cardiac Tropism of Borrelia burgdorferi: An Autopsy Study of Sudden Cardiac Death Associated with Lyme Carditis. Am J Pathol. 2016;186(5):1195-1205.
  9. Yoon EC, Vail E, Kleinman G, et al. Lyme disease: a case report of a 17-year-old male with fatal Lyme carditis. Cardiovasc Pathol. 2015;24(5):317-321.
  10. Kwon HY, Im JH, Park YK, Durey A, Lee JS, Baek JH. Two Imported Cases of Babesiosis with Complication or Co-Infection with Lyme Disease in Republic of Korea. Korean J Parasitol. 2018;56(6):609-613.
_______________________
For more: